ST 2825 is used in drug research and development, particularly in inhibiting the function of proteins involved in inflammatory processes and cancer. It is studied to evaluate its efficacy in suppressing signaling pathways of molecules associated with inflammation and cancer cell growth. Additionally, ST 2825 is employed in clinical trials to assess its efficacy and safety in treating diseases related to chronic inflammation and cancer.